CLX CLOROX CO /DE/
Specialty Cleaning, Polishing and Sanitation Preparations · NYSE · SEC CIK 21076 · Fiscal year ends 06/30
Financial factors as of 2025-09-30 (2026Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY-9.3%
TTM net income YoY121.6%
TTM EPS YoY121.2%
Revenue 3-yr CAGR-1.3%
Net income 3-yr CAGR25.0%
Margins
Gross margin44.3%
Operating margin—
Net margin11.7%
FCF margin9.4%
EBITDA margin—
Returns
ROE4,163.2%
ROA14.3%
ROIC (approx.)—
Asset turnover1.23x
Leverage & solvency
Liabilities / assets97.5%
Debt / equity—
Current ratio0.76x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.08x
Accruals ratio-1.1%
Payout ratio76.1%
Capex / revenue3.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-06-30 | FY20242024-06-30 |
|---|---|---|
| Income statement | ||
| Revenue | $7.10B | $7.09B |
| Cost of revenue | $3.89B | $4.04B |
| Gross profit | $3.21B | $3.05B |
| R&D expense | $121.00M | $126.00M |
| SG&A expense | $1.12B | $1.17B |
| Interest expense | $88.00M | $90.00M |
| Pretax income | $1.08B | $398.00M |
| Income tax | $254.00M | $106.00M |
| Net income | $810.00M | $280.00M |
| EPS (basic) | 6.56 | 2.26 |
| EPS (diluted) | 6.52 | 2.25 |
| Dividends declared per share | 4.88 | 4.80 |
| Weighted avg. shares (diluted) | 124.29M | 124.80M |
| Balance sheet | ||
| Cash & equivalents | $170.00M | $207.00M |
| Receivables | $821.00M | $695.00M |
| Inventory | $523.00M | $637.00M |
| Current assets | $1.61B | $1.62B |
| PP&E, net | $1.27B | $1.31B |
| Goodwill | $1.23B | $1.23B |
| Intangibles | $566.00M | $681.00M |
| Total assets | $5.56B | $5.75B |
| Current liabilities | $1.92B | $1.57B |
| Short-term debt | $0 | $0 |
| Long-term debt | $2.48B | $2.48B |
| Total debt | $2.48B | $2.48B |
| Total liabilities | $5.08B | $5.26B |
| Shareholders' equity | $321.00M | $328.00M |
| Net debt | $2.31B | $2.27B |
| Shares outstanding | 122.69M | 124.20M |
| Cash flow statement | ||
| Operating cash flow | $981.00M | $695.00M |
| Capital expenditure | $220.00M | $212.00M |
| Free cash flow | $761.00M | $483.00M |
| Investing cash flow | -$94.00M | -$175.00M |
| Financing cash flow | -$924.00M | -$655.00M |
| Depreciation & amortization | $219.00M | $235.00M |
| Stock-based compensation | $81.00M | $74.00M |
| Dividends paid | $602.00M | $595.00M |
| Share buybacks | $332.00M | $0 |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.